Rodger Novak, Chief Executive Officer at CRISPR Therapeutics AG (CRSP), sold 36,940 shares at $20.87 ($767K) on 2017-08-31, disclosed to the SEC on 2017-09-05.
Open-market sale of $767k CRSP by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.87 | 14,617 | $305K | 39.8% |
| 2 | $20.87 | 14,617 | $305K | 39.8% |
| 3 | $20.33 | 3,853 | $78K | 10.2% |
| 4 | $20.33 | 3,853 | $78K | 10.2% |
| Total | $20.76 avg | 36,940 | $767K | 100% |
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |